-
Blog BLOG
-
Product Center BRAND DYNAMICS
-
Investor INVESTOR RELATIONS
-
Contact Us CONTACT
-
Supervise SUPERVISION
Innovation Drives High-Quality Development: Dr. Jin Fang, Chief Scientist of Health Yuan, Attends the First Session of the 14th National People's Congress
Published Time:
2023-03-10
The 2023 Government Work Report pointed out the need to effectively guarantee the public's access to medical care and medicine, safeguarding people's lives and health. This has once again brought the promotion of domestic innovative drug development into focus. Dr. Jin Fang, Chief Scientist of Healthyuan Pharmaceutical Group, attended the first session of the 14th National People's Congress as a national deputy. 。
Dr. Jin Fang, National People's Congress deputy and Chief Scientist of Healthyuan.
Representative Jin Fang has been deeply engaged in the R&D of respiratory drugs and the industrialization of high-end complex inhalation formulations for more than 30 years. With her professional dedication and pursuit of excellence, she has broken through the technological monopoly and 'bottleneck' barriers of a few multinational pharmaceutical companies internationally. 'For health, for tomorrow, wholeheartedly making good medicine and new medicine'. This is the mission and vision, and a series of innovative achievements have been made in the field of respiratory medication.
Representative Jin Fang stated, COPD is one of the diseases with the highest incidence and mortality rates worldwide, Most COPD patients, even when they perceive physical discomfort, do not actively seek medical attention, further missing the opportunity for treatment. Currently, there are more than 100 million COPD patients in China, but the public awareness of the disease is less than 5%. Although the Chronic Respiratory Disease Action Plan has been listed as one of the major actions in the Healthy China 2030 initiative, it has not yet been included in the national basic public health service program and has not yet received widespread social attention. Therefore, it is hoped that support can be provided for research on early intervention of COPD, and that public education can be carried out throughout society to raise public awareness. Next, she will continue to work with her team to explore and research new drugs, continuously developing more new and good drugs needed by the public, promoting the high-quality development of domestic biomedicine, and showcasing the strong potential of Chinese pharmaceutical companies to the world.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home